Evidence synthesis and recommendations: clinical practice guidelines for the management of retinopathy of prematurity
Introduction
Retinopathy of prematurity (ROP) is a potentially serious preventable disease that can present in up to 34% of preterm newborns. The World Health Organization includes the management of this entity among its priority policies for reducing the prevalence of preventable blindness.

